The Normandy Particle Therapy Centre (CYCLHAD/ARCHADE) began treating patients with the Centre François Baclesse (CFB) in end of July 2018 using the IBA Proteus One solution after three weeks of acceptance testing and two months commissioning. In December 2018, more than 20 patients have completed their treatment. The CYCLHAD centre Proteus One is equipped with the IBA S2C2 (superconducting synchrocyclotron), a 220° compact gantry, stereoscopic imaging system and a 6D Leoni Orion System robotic couch.
This work summarizes and presents the various steps of the system characterization as well as machine quality assurance (QA) program.
These validations tests and QA procedure ensure the reliability of the proton system for clinical activities.
Further testing with anthropomorphic head phantoms were performed (for more details see the poster: Thorough dosimetric evaluation of optimization techniques with an anthropomorphic head phantom).

03 - From commissioning to treatment with the ProteusOne at the Normandy Particle Therapy Centre